In our study, we also found that myofibroblast-specific Irx2 depletion, but not cardiomyocyte-specific Irx2 depletion, could attenuate cardiac hypertrophy, and improve cardiac systolic function. This evidence concerns the gene IRX2 and cardiac hypertrophy.